Please try another search
SAN DIEGO - The European Commission has granted conditional marketing authorization for FILSPARI (sparsentan), a treatment for adults with primary IgA nephropathy (IgAN), announced Travere...
First non-immunosuppressive therapy for the treatment of IgA Nephropathy (IgAN) approved in EuropeConditional marketing authorization is based on statistically significant and clinically meaningful...
On Thursday, H.C. Wainwright adjusted its outlook on Travere Therapeutics (NASDAQ:TVTX), increasing the price target to $19 from the previous $17, while maintaining a Buy rating on the stock.The...
Scientific Games (NASDAQ:PRFT) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.The long-term earnings growth rate for ManTech...
Shares of Incyte Corporation (NASDAQ:LLY) and Incyte Corporation announced positive top-line data from two late-stage studies, evaluating their oral JAK inhibitor, Olumiant (baricitinib) as...
IGas Energy PLC (LON:IGAS) has released an initial update on drilling activity at Springs Road, with over 250m of hydrocarbon bearing shale encountered. Pressurised core samples were shown to release...
Instrument Type
Region
Sector
Industry
Date
Category
Provider